Executive functioning profiles from the BRIEF across pediatric medical disorders: Age and diagnosis factors

Lauren S Krivitzky1, Karin S Walsh2,3, Evelyn L Fisher2

  • 1a Children's Hospital of Philadelphia and Perelman School of Medicine , University of Pennsylvania , Philadelphia , USA.

Insights

Children with medical conditions often experience executive functioning (EF) challenges, particularly in working memory and planning. Earlier diagnosis and evaluation correlate with more significant EF problems.

Area of Science:

  • Neuroscience
  • Pediatric Psychology
  • Clinical Psychology

Background:

  • Executive functioning (EF) is crucial for cognitive and behavioral regulation.
  • Pediatric medical conditions can significantly impact a child's EF.
  • Understanding EF profiles across diverse medical conditions is essential for targeted interventions.

Purpose of the Study:

  • To compare executive functioning (EF) profiles in children with various medical conditions.
  • To investigate the influence of age at diagnosis and evaluation on EF.
  • To identify specific EF domains most affected by pediatric medical disorders.

Main Methods:

  • Retrospective, cross-sectional study of 734 children (5-18 years).
  • Inclusion of five medical groups (brain tumor, leukemia, epilepsy, neurofibromatosis type 1, ornithine transcarbamylase deficiency), ADHD controls, and healthy controls.
  • Utilized the Behavior Rating Inventory of Executive Functioning (BRIEF) parent-report and repeated measures ANOVA.

Main Results:

  • Attention deficit hyperactivity disorder (ADHD) group exhibited the highest EF problems.
  • Neurofibromatosis type 1 (NF1) and ornithine transcarbamylase deficiency (OTC-D) groups showed significantly more EF problems than healthy controls.
  • Working memory and planning/organizing were the most affected EF domains across medical groups.

Conclusions:

  • Children with medical disorders are 2-4 times more likely to have clinically significant EF problems.
  • Earlier age of diagnosis and evaluation was associated with greater reported EF difficulties.
  • Findings highlight the need for interventions addressing EF deficits in pediatric medical populations.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
802
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
776
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
1.4K
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
1.1K